 |
市場調査レポート
商品コード
956201
世界の癌ワクチン市場規模調査：種類別、技術別、適応別、エンドユーザー別、および地域別予測：2020～2027年Global Cancer Vaccines Market Size study, by Type, by Technology, by Indication, by End-User and Regional Forecasts 2020-2027 |
||||||
| 世界の癌ワクチン市場規模調査：種類別、技術別、適応別、エンドユーザー別、および地域別予測：2020～2027年 |
|
出版日: 2020年08月28日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
|
世界の癌ワクチンの市場規模は2019年に約42億米ドルと評価されており、予測期間の2020～2027年には12.6％を超える健全な成長率で成長すると予測されています。
癌ワクチンは免疫療法の一種であり、生物学的応答修飾因子と見なされています。通常、癌治療ワクチンは、細菌やウイルスに対して作用するワクチンとは異なります。癌ワクチンは、患者の体の免疫系を刺激して癌細胞と闘うことができます。これらのワクチンは、病気を予防するのではなく、主に免疫系を強化して、すでに患者の体内ですでに発生している病気を治療することに注力します。
癌ワクチンは一般的に2つのタイプ、すなわち予防用癌ワクチンと治療用癌ワクチンがあります。予防用癌ワクチンは通常、健康な人々の間で癌疾患を予防するために使用されますが、治療用癌ワクチンは、疾患と闘うために患者の免疫反応を強化するために使用されます。
癌患者数の増加、癌治療に対する患者の意識の高まり、および癌ワクチンの開発への投資と政府資金の増加は、予測期間中の市場のCAGRを担う要因となっています。国際癌調査機関（IARC）によると、2018年に世界中で約1,810万件の新規癌症例と960万件の癌による死亡が報告されました。また、世界での癌の罹患動向は、2040年までに、新規症例数が約2,750万件、癌による死亡者数が1,630万人近くに増加すると予測されています。これは、世界的に癌ワクチンに対する需要を高めることになるでしょう。ただし、ワクチンの開発コストの高さ、製品認可に関する厳格な政府の規範とポリシーが、2020年から2027年の予測期間における市場の成長を妨げる要因となっています。
当レポートでは、世界の癌ワクチン市場について調査し、市場の概要とともに、種類別、技術別、適応別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。Title:
Global Cancer Vaccines Market Size study, by Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), by Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), by Indication (Cervical Cancer, Prostate Cancer, Others), by End-User (Pediatrics, Adults) and Regional Forecasts 2020-2027.
Global Cancer Vaccines Market is valued at approximately USD 4.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.6% over the forecast period 2020-2027. Cancer vaccines are a form of immunotherapy which is considered as a biological response modifier. Usually, cancer treatment vaccines are distinct from the vaccines that work against bacteria and viruses. Cancer vaccines can stimulate the immune system of the patient's body to fight against cancer cells. Rather than preventing disease, these vaccines are primarily focused to boost the immune systems to medicate a disease that already occurred in the patient's body. The cancer vaccines are generally available in two types i.e. preventive cancer vaccines and therapeutic cancer vaccines. Preventive cancer vaccines are typically used to prevent cancer disease among healthy people, whereas therapeutic cancer vaccines are used to strengthen the immune response among patients to fight against the disease. An increase in the number of cancer patients, growing awareness among patients towards cancer therapy, and rising investment and government funding in the development of cancer vaccine are the few factors responsible for the CAGR of the market during the forecast period. According to the International Agency for Research on Cancer (IARC), around 18.1 million new cancer cases and 9.6 million cancer deaths were reported throughout the world in 2018. Also, the global prevalence of cancer is projected to grow to around 27.5 million new cancer cases and nearly 16.3 million cancer deaths by the year 2040. This, in turn, is likely to strengthen the demand for Cancer Vaccines, globally. However, the high development cost of vaccine and stringent government norms & policies on product approval are the few factors impeding the market growth over the forecast period of 2020-2027.
The regional analysis of the global Cancer Vaccines market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the favorable government support for the approval of cancer vaccines, along with the wide presence of market players in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of cancer and improving healthcare infrastructure in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the cancer vaccine market in the Asia-Pacific region.
Major market player included in this report are:
Advaxis Inc.
Amgen Inc.
Dynavax Technologies Corporation
Generex Biotechnology Corporation
GlaxoSmithKline plc (GSK)
Immunocellular Therapeutics, Ltd.
Merck & Co., Inc.
Sanpower Group Co. Ltd.
UbiVac, Inc.
Vaccinogen, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
By Technology:
Dendritic Cells (DC) Cancer Vaccines
Recombinant Cancer Vaccines
Antigen/Adjuvant Cancer Vaccines
Viral Vector & DNA Cancer Vaccines
By Indication:
Cervical Cancer
Prostate Cancer
Others
By End-User:
Pediatrics
Adults
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2017, 2018
Base year - 2019
Forecast period - 2020 to 2027
Target Audience of the Global Cancer Vaccines Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
比較リスト
